FIELD: medicine.
SUBSTANCE: one or more cytostatic agents are administered in an amount of 1/4 to Ѕ of a standard therapeutic dose, which is followed by a subcutaneous administration of N-acetyl-D-glucoaminyl-β-(1-4)-N-acetylmuramyl-L-alanyl-D-glutamic acid (GMDP-A) in an effective amount once a day for 4-20 days.
EFFECT: method ensures increasing therapeutic effectiveness by a synergetic effect of the immune-modifying agent and cytostatic agent with reducing a therapeutic dose of the cytostatic agents with preserving their anti-tumour effectiveness.
4 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINED CONSERVATIVE EFFECT ON MALIGNANT TUMOURS | 2008 |
|
RU2392935C1 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| COMPOSITION FOR KILLING TNF-α-SENSITIVE TUMOR CELLS | 2002 |
|
RU2209078C1 |
| COMPOSITION FOR PREPARATION OF ANTI-TUMOR MEDICATION AND METHOD FOR PREPARATION OF ANTI-TUMOR MEDICATION BASED ON IT | 2016 |
|
RU2667128C2 |
| IMMUNOMODULATING AGENT AND A PHARMACEUTICAL COMPOSITION EXHIBITING ANTITUMOR ACTIVITY | 1997 |
|
RU2121363C1 |
| METHOD OF TREATING SEPTIC SHOCK AND USING MURAMYL COMPOUNDS | 1992 |
|
RU2139086C1 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
| SET OF DRUGS FOR CONDUCTING A COURSE OF TERTIARY PREVENTION OF ONCOLOGICAL DISEASES FOR IMMUNOMODULATORY EFFECTS IN COMBINATION THERAPY AND A METHOD FOR TERTIARY PREVENTION OF ONCOLOGICAL DISEASES USING COMBINATION THERAPY USING A SET OF DRUGS FOR IMMUNOMODULATING EFFECTS | 2022 |
|
RU2794024C1 |
| METHOD FOR POTENTIATING ACTIVITY OF ANTI-TUMOUR CYTOTOXIC PREPARATIONS | 2017 |
|
RU2714140C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
